Newsfeeds - Spark Newswire

4 minute read

58 Stocks Moving In Thursday’s Mid-Day Session

Today, 5:23 AM

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

ABVC

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 5:23 AM

Gainers

CLPT

1 minute read

ClearPoint Neuro Q1 EPS $(0.17) Beats $(0.20) Estimate, Sales $5.00M Beat $4.18M Estimate

By Michael Horton

Today, 5:23 AM

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 30.77 percent decrease over losses of $(0.13) per share from the

CLPT

12 minute read

Earnings Scheduled For May 11, 2022

By Benzinga Insights

Today, 5:23 AM

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

ACOR

1 minute read

FDA
News

ClearPoint Neuro Teceives FDA 510(k) Clearance For ClearPoint Array System

By Benzinga Newsdesk

Today, 5:23 AM

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K214040

CLPT

1 minute read

B. Riley Securities Reinstates Buy on ClearPoint Neuro, Announces $15 Price Target

By Benzinga Newsdesk

Today, 5:23 AM

B. Riley Securities analyst Marc Wiesenberger reinstates ClearPoint Neuro (NASDAQ:CLPT) with a Buy and announces $15 price target.

CLPT

1 minute read

Earnings

ClearPoint Neuro: Q4 Earnings Insights

By Benzinga Insights

Today, 5:23 AM

ClearPoint Neuro (NASDAQ:CLPT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro reported in-line EPS of $-0.19 versus an estimate of $-0.19.

CLPT